Skip to main content
. 2016 Oct 26;7(48):78918–78931. doi: 10.18632/oncotarget.12912

Figure 4. Representative lesions for DDR2 immunostaining reveals DDR2 is undetected in normal urothelium.

Figure 4

(A1), and urothelial dysplasia (A2), and non-invasive papillary urothelial carcinoma (B). There is an escalated increase of immunoacitvity from superficial invasive (C) to muscle invasive (D) urothelial carcinoma.